These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 884149)

  • 1. The perturbation of thrombin binding to human platelets by trypsin and neuraminidase.
    Ganguly P
    Biochim Biophys Acta; 1977 Jun; 498(1):21-8. PubMed ID: 884149
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of trypsin and neuraminidase on content of serotonin in rat blood platelets.
    Koćmierska-Grodzka D
    Arch Immunol Ther Exp (Warsz); 1976; 24(4):565-73. PubMed ID: 999471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on platelet function of removal of platelet sialic acid by neuraminidase.
    Greenberg J; Packham MA; Cazenave JP; Reimers HJ; Mustard JF
    Lab Invest; 1975 Apr; 32(4):476-84. PubMed ID: 1127870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of thrombin binding and serotonin secretion from platelets by a 74,000 dalton protein.
    Ganguly P; Fossett NG
    Biochem Biophys Res Commun; 1983 Apr; 112(1):228-34. PubMed ID: 6838608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of immobilized neuraminidase on the accumulation of 5-hydroxytryptamine by human platelets.
    Masters VM; Webster J; Cook GM
    Biochem Pharmacol; 1980 Dec; 29(23):3189-201. PubMed ID: 7447956
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin.
    McNicol A; Robson CA
    J Pharmacol Exp Ther; 1997 May; 281(2):861-7. PubMed ID: 9152395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Platelet aggregation from interaction between washed platelets and purified thrombin, plasmin or trypsin (author's transl)].
    Matsuoka M; Watanabe T; Koike K; Sakuragawa N
    Rinsho Ketsueki; 1974 May; 15(5):519-23. PubMed ID: 4277899
    [No Abstract]   [Full Text] [Related]  

  • 8. Trypsin-induced phospholipase activity in human platelets.
    Pickett WC; Jesse RL; Cohen P
    Biochem J; 1976 Nov; 160(2):405-8. PubMed ID: 827290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide.
    Pearlstein E; Ambrogio C; Gasic G; Karpatkin S
    Cancer Res; 1981 Nov; 41(11 Pt 1):4535-9. PubMed ID: 7306974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet thrombin receptors. Binding of alpha-thrombin is coupled to signal generation by a chymotrypsin-sensitive mechanism.
    Tam SW; Fenton JW; Detwiler TC
    J Biol Chem; 1980 Jul; 255(14):6626-32. PubMed ID: 7391039
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of local anaesthetics with blood platelet aggregation.
    Jancinová V; Nosál' R; Benes L
    Drugs Exp Clin Res; 1986; 12(9-10):857-60. PubMed ID: 3792211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity studies of the thrombin receptor activating peptide.
    Sabo T; Gurwitz D; Motola L; Brodt P; Barak R; Elhanaty E
    Biochem Biophys Res Commun; 1992 Oct; 188(2):604-10. PubMed ID: 1332704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of separate proteolytic and high-affinity binding activities of human thrombin on rapid platelet activation. A quenched-flow study.
    Jones GD; Carty DJ; Freas DL; Spears JT; Gear AR
    Biochem J; 1989 Sep; 262(2):611-6. PubMed ID: 2803271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypersensitivity to thrombin of platelets from diabetic rats is not due to increased thrombin binding.
    Winocour PD; Perry DW; Hatton MW; Kinlough-Rathbone RL
    Thromb Res; 1991 Feb; 61(4):469-75. PubMed ID: 2063351
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding of the products of prothrombin activation to human platelets.
    Tollefsen DM; Jackson CM; Majerus PW
    J Clin Invest; 1975 Jul; 56(1):241-5. PubMed ID: 1141438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shape change and the percentage of sialic acid removed by neuraminidase from human platelets.
    Peerschke EI; Zucker MB
    Proc Soc Exp Biol Med; 1978 Oct; 159(1):54-6. PubMed ID: 714935
    [No Abstract]   [Full Text] [Related]  

  • 18. YD-3, a novel inhibitor of protease-induced platelet activation.
    Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of thrombin and trypsin on calcium uptake by calf platelet membranes.
    Robblee LS; Shepro D; Belamarich FA
    Microvasc Res; 1973 Jul; 6(1):99-107. PubMed ID: 4737682
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of tryptic fragments of von Willebrand factor involved in binding to thrombin-activated platelets with fragments involved in ristocetin-induced binding and binding to collagen.
    Houdijk WP; Girma JP; van Mourik JA; Sixma JJ; Meyer D
    Thromb Haemost; 1986 Dec; 56(3):391-6. PubMed ID: 3551182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.